CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
Masahiro Nishikawa(Ehime University), Takeharu Kunieda(Ehime University), Seiji Shigekawa(Ehime University), Hideaki Watanabe(Showa University Northern Yokohama Hospital), Akihiro Inoue(Ehime University), Takanori Ohnishi(Saiseikai Matsuyama Hospital), Junya Tanaka(Ehime University), Shohei Kohno(Ehime University), Hajime Yano(Ehime University), Saya Ozaki(Ehime University), Shiro Ohue(Ehime Prefectural Central Hospital), Shirabe Matsumoto(Ehime University), Satoshi Suehiro(Ehime University), Yonehiro Kanemura(Osaka National Hospital), Yawara Nakamura(Ehime University), Riko Kitazawa(Ehime University Hospital)
Cited by 26
Related Papers
Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
|Stem Cells International|2018|68
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma
|Translational Oncology|2021|26
Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro
|Molecular Brain|2021|21
Met-PET uptake index for total tumor resection: identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma
|Neurosurgical Review|2020|20
Tricks and traps of ICG endoscopy for effectively applying endoscopic transsphenoidal surgery to pituitary adenoma
|Neurosurgical Review|2020|20